-
Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?Dimopoulos K, Ernst S, McCabe C et al. -
Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patientsMS Jördens, M Luedde, C Roderburg et al.
-
Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary HypertensionY-P Zhou , Y-P Wei , Y-J Yang et al.
-
Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertensionWT Chang, JY Shih, ChS Hong et al.
-
A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions.LC Steffes, AA Froistad, ME Kumar et al.
-
The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary HypertensionCCW Lo, SM Moosavi, KJ Bubb et al.
-
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionESC/ERS Scientific Document Groupnt of pulmonary hypertension
-
Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA TrialJ Zhang, J Kan, S-L Chen et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
